Back
LendingTree, Inc. Vs. Ultragenyx Pharmaceutical, Inc. Industry Stock Comparison
Buy
60
TREE
LendingTree, Inc.
Last Price:
$54.12
Seasonality Move:
16.88%
Sell
48
RARE
Ultragenyx Pharmaceutical, Inc.
Last Price:
$36.24
Seasonality Move:
6.21%
Buy
60
LendingTree, Inc. (TREE)
is a Buy
Is LendingTree, Inc. a Buy, Sell or Hold?
-
The current LendingTree, Inc. [TREE] share price is $54.06. The Score for TREE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
TREE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Ultragenyx Pharmaceutical, Inc. (RARE)
is a Sell
Is Ultragenyx Pharmaceutical, Inc. a Buy, Sell or Hold?
-
The current Ultragenyx Pharmaceutical, Inc. [RARE] share price is $36.23. The Score for RARE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TREE Stock Price Chart
What is LendingTree, Inc.'s stock price today?
-
The LendingTree, Inc. share price today is $54.06Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TREE is experiencing selling pressure, which indicates risk of future bearish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical, Inc.'s stock price today?
-
The Ultragenyx Pharmaceutical, Inc. share price today is $36.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.
TREE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 45.86 | Sell |
| Chaikin Money Flow: | -188797 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.27 - 56.31) | Buy |
| Bollinger Bands (100): | (52.39 - 68.13) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.99 | Buy |
| Relative Strength Index (14 RSI): | 61.17 | Buy |
| Chaikin Money Flow: | -31475 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.18 - 35.78) | Buy |
| Bollinger Bands (100): | (28.77 - 33.95) | Buy |
TREE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.6 | Sell |
| 20-day SMA: | 53.6 | Buy |
| 50-day SMA: | 56.57 | Sell |
| 200-day SMA: | 51.01 | Buy |
| 8-day EMA: | 55.2 | Sell |
| 20-day EMA: | 55.06 | Sell |
| 50-day EMA: | 56.57 | Sell |
| 200-day EMA: | 53.07 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.32 | Sell |
| 20-day SMA: | 34.36 | Buy |
| 50-day SMA: | 33.41 | Buy |
| 200-day SMA: | 33.75 | Buy |
| 8-day EMA: | 35.88 | Buy |
| 20-day EMA: | 34.85 | Buy |
| 50-day EMA: | 33.54 | Buy |
| 200-day EMA: | 34.8 | Buy |
LendingTree, Inc. Earnings Growth & TREE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.12 per share, and an increase next year of $0.31 per share.
Ultragenyx Pharmaceutical, Inc. Earnings Growth & RARE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $1.31 per share.
LendingTree, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||